In dermal MCTs, what was the HR for recurrence/metastasis in the high mitotic count group compared with the low mitotic count group?

Study for the ACVIM Small Animal Internal Medicine Exam to enhance your veterinary knowledge. Prepare with flashcards and multiple-choice questions, featuring hints and explanations. Ensure success in your exam journey!

High mitotic activity in dermal mast cell tumors signals a more aggressive tumor biology, which translates into a higher risk of adverse outcomes over time. In survival analysis, the hazard ratio compares the instantaneous risk of an event between two groups across the follow-up period. An HR of 11.1 means that at any point in time, dogs with a high mitotic count have about 11 times the risk of recurrence or metastasis compared with dogs with a low mitotic count, assuming the model’s proportional hazards hold. This large value indicates a strong prognostic impact of mitotic count on recurrence/metastasis. Of course, the exact interpretation depends on the study’s confidence interval and design, but the point estimate shows a markedly higher risk associated with high mitotic count.